Literature DB >> 20353389

The association of lipodystrophy and oxidative stress biomarkers in HIV-infected men.

Helena S Vassimon1, Rafael Deminice, Alcyone A Machado, Jacqueline P Monteiro, Alceu Afonso Jordao.   

Abstract

The aim of this study was to describe the status of oxidative stress and antioxidant biomarkers and their association with metabolic and body composition components of HIV-lipodystrophy syndrome. In a cross-sectional study of blood samples from HIV-infected men with lipodystrophy syndrome (HIV+LIPO+ = 10), HIV-infected men without lipodystrophy syndrome (HIV+LIPO- = 22), and healthy subjects (control = 12), the following oxidative stress biomarkers were analyzed: total hydroperoxide, thiobarbituric acid reactive substances (TBARS), and advanced oxidation protein products (AOPP). In addition, antioxidant biomarkers, including total glutathione, uric acid, alpha-tocopherol, and metabolic components were tested. Dual-energy x-ray absorciometry (DXA) was used to measure the fat mass. The duration of HIV infection and the duration and type of highly active antiretroviral therapy were similar between the two HIV-infected groups. Higher levels of total hydroperoxide were observed in the HIV+LIPO+ (50 +/- 33 H(2)O(2)/L) group compared to the HIV+LIPO- (19 +/- 13 H(2)O(2)/L) and control (5 +/- 5 H(2)O(2)/L) groups (p < 0.05). Similarly, higher levels of AOPP were observed in the HIV+LIPO+ (326 +/- 173 micromol/L) group compared to the HIV+LIPO- (105 +/- 92 micromol/L) and control groups (80 +/- 20 micromol/L) (p < 0.05). Total hydroperoxide significantly correlated with insulin serum levels in the HIV+LIPO+ (r = 0.47, p < 0.05) and HIV+LIPO- groups (r = 0.29, p < 0.05), while AOPP significantly correlated with insulin serum levels in the HIV+LIPO+ (r = 0.73, p < 0.05) and HIV+LIPO- (r = 0.54, p < 0.05) groups. Therefore, higher lipid and protein oxidation were found in HIV-infected patients with lipodystrophy syndrome, and both were associated with insulin levels.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20353389     DOI: 10.2174/157016210791330347

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  5 in total

1.  Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine.

Authors:  Smita S Ghare; Hridgandh Donde; Wei-Yang Chen; David F Barker; Leila Gobejishvilli; Craig J McClain; Shirish S Barve; Swati Joshi-Barve
Journal:  Toxicol In Vitro       Date:  2016-05-26       Impact factor: 3.500

Review 2.  Treatment of dyslipidemia in HIV.

Authors:  Rajagopal V Sekhar
Journal:  Curr Atheroscler Rep       Date:  2015-04       Impact factor: 5.113

3.  Effect of increasing glutathione with cysteine and glycine supplementation on mitochondrial fuel oxidation, insulin sensitivity, and body composition in older HIV-infected patients.

Authors:  Dan Nguyen; Jean W Hsu; Farook Jahoor; Rajagopal V Sekhar
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

4.  New and emerging agents in the management of lipodystrophy in HIV-infected patients.

Authors:  Eric Bonnet
Journal:  HIV AIDS (Auckl)       Date:  2010-09-17

5.  Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients.

Authors:  Mar Masiá; Sergio Padilla; Marta Fernández; Carmen Rodríguez; Ana Moreno; Jose A Oteo; Antonio Antela; Santiago Moreno; Julia Del Amo; Félix Gutiérrez
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.